Upon endocrinological assessment at admission, a lab assessment including tumor markers, revealed no abnormalities other than hypoglycemia (2.04 mmol/L) and suppressed serum insulin (<0.2 mU/L) and C-peptide (0.08 ng/ml) but no anti-insulin antibodies. The gene discussed is INS; the disease is neoplasm.